Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

QR Code

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

Hisashi Higuchi1, Kazuhiro Sato2, Shingo Naito3, Keizo Yoshida4, Hitoshi Takahashi5, et al1Department of Neuropsychiatry, St Marianna University School of Medicine, 2-16-1 Sugou, Miyamae-ku, Kawasaki City, Kanagawa 216-8511, Japan; 2Department of Psychiatry, Akita Kaiseikai Hospital, 1-7-5 Ushijima-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hisashi Higuchi, Kazuhiro Sato, Shingo Naito, Keizo Yoshida, Hitoshi Takahashi, et al
Format:	article
Language:	EN
Published:	Dove Medical Press 2009
Subjects:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Online Access:	https://doaj.org/article/843b4a99151b48f4959efba9700773d5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
by: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et al.
Published: (2009)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
by: Yoshimura R, et al.
Published: (2017)

Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study
by: Yahno NN, et al.
Published: (2017)

Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population
by: Kawamura S,&nbsp;Maesawa C,&nbsp;Nakamura K,&nbsp;Nakayama K,&nbsp;Morita M,&nbsp;Hiruma Y,&nbsp;Yoshida T,&nbsp;Sakai A,&nbsp;Masuda T
Published: (2011)

The Effect Of Fluvoxamine On Sleep Architecture Of Depressed Patients With Insomnia: An 8-Week, Open-Label, Baseline-Controlled Study
by: Hao Y, et al.
Published: (2019)

Management of obsessive-compulsive disorder with fluvoxamine extended release
by: L&iacute;dia Ordacgi, et al.
Published: (2009)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
by: Kamijima K, et al.
Published: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
by: Kamijima K, et al.
Published: (2013)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
by: Kuga A, et al.
Published: (2017)

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms
by: Park CM, et al.
Published: (2014)

Trazodone effects on [3H]-paroxetine and &alpha;2-adrenoreceptors in platelets of patients with major depression
by: Donatella Marazziti, et al.
Published: (2010)

Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach
by: Hasanpour H, et al.
Published: (2019)

Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
by: Michele Fornaro
Published: (2010)

Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
by: Hasanpour H, et al.
Published: (2018)

Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression
by: Takahashi H, et al.
Published: (2017)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
by: Otsubo T, et al.
Published: (2018)

Getting the balance right: Established and emerging therapies for major depressive disorders
by: Bojana Perovic, et al.
Published: (2010)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
by: Marty Hinz, et al.
Published: (2010)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
by: Kuga A, et al.
Published: (2017)

Desvenlafaxine in the treatment of major depressive disorder
by: Maria Teresa C Lourenco1, et al.
Published: (2009)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
by: Tomita T, et al.
Published: (2014)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
by: Sugawara N, et al.
Published: (2020)

Psychiatric comorbidities in patients with major depressive disorder
by: Thaipisuttikul P, et al.
Published: (2014)

Transcranial magnetic stimulation for the treatment of major depression
by: Janicak PG, et al.
Published: (2015)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Retraction]
by: Hinz M, et al.
Published: (2020)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
by: Alla Avedisova, et al.
Published: (2009)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
by: Laura Gedge, et al.
Published: (2010)

Clinical effectiveness of 1 Hz/20 Hz bilateral rTMS treatment in adolescents with major depressive disorder
by: Paul Croarkin, et al.
Published: (2021)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Expression of Concern]
by: Hinz M, et al.
Published: (2020)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
by: Dannehl K, et al.
Published: (2014)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
by: Mazen K Ali, et al.
Published: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
by: J Craig Nelson, et al.
Published: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
by: Tobe EH
Published: (2013)

The cortisol awakening response and major depression: examining the evidence
by: Dedovic K, et al.
Published: (2015)

Levomilnacipran for the treatment of major depressive disorder: a review
by: Asnis GA, et al.
Published: (2015)

Is placebo useful in the treatment of major depression in clinical practice?
by: Marchesi C, et al.
Published: (2013)

Psychomotor retardation and externally oriented thinking in major depression
by: Luca M, et al.
Published: (2013)

The effect of depression on fracture healing and osteoblast differentiation in rats
by: Nie C, et al.
Published: (2018)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
by: Kuga A, et al.
Published: (2019)

Major depressive disorder: mechanism-based prescribing for personalized medicine
by: Saltiel PF, et al.
Published: (2015)